Cognition Therapeutics KOL Event Provided Platform for Valua

Cognition Therapeutics KOL Event Provided Platform for Valuable Discussion of Current Therapeutic Options and Need for Additional Options to Treat Alzheimer's disease

PURCHASE - Cognition Therapeutics, Inc., , a clinical stage company developing drugs that treat neurodegenerative disorders, provided a recap of the virtual KOL event hosted on April 12, 2024...

Related Keywords

Amsterdam , Noord Holland , Netherlands , Anton Porsteinsson , Jort Vijverberg , Mike Moyer , Casey Mcdonald , Martinj Sadowski , Lisa Ricciardi , Company Or Cognition , Securities Exchange Commission , Cognition Therapeutics Inc , Alzheimer Center Amsterdam , University Of Rochester Alzheimer Disease Care , School Of Medicine , Education Program , Rochester Alzheimer , Disease Care , Private Securities Litigation Reform Act , Risk Factor , Exchange Commission , News Publishing , Markets ,